A

Astellas Venture Capital L.L.C.

10 employees

Astellas Venture Management is a California-based financial organization that targets investments in the biotechnology sector.

Investor insights

Sectors invested in

Biotechnology42
Health Care25
Therapeutics24
Medical18
Pharmaceutical12
Genetics8
Life Science7
Medical Device5
Drug Discovery4
Oncology3
Beauty2
Phage Display2
Peptide Therapeutics2
Immune-Oncology Therapeutics2
Developer Platform2
Biopharma2
Small Molecule Therapeutics2
Cancer2
Immuno-oncology2
Translational Medicine2

Funding rounds participated in

$1.5M sweet spot round size

Most of their 48 investments are in rounds between $14M and $39M

Investor type

Corporate Venture Capital
Entrepreneurship Program

Basic info

Sectors

Biotechnology
Health Care
Venture Capital

Date founded

2005

Investments made

M

Mogrify raised $10M on October 2, 2023

Investors: Ahren Innovation Capital, Parkwalk Advisors and Astellas Venture Capital L.L.C.

A

Avilar Therapeutics raised $15M on February 16, 2023

Investors: Sanofi Ventures, RA Capital Management, L.P., Medical Excellence Capital, LLC and Astellas Venture Capital L.L.C.

N

NeoPhore Ltd raised $7.4M on January 19, 2023

Investors: SIXTH ELEMENT CAPITAL LLP, 3B Future Health Fund, Claris Ventures SGR SpA and Astellas Venture Capital L.L.C.

C

Casma Therapeutics raised $46M on November 15, 2022

Investors: Eventide Management Partners, Schroders Capital, The Column Group, Eisai Asia, Mirae Asset MAPS Global Investments Co., Ltd, Third Rock Ventures and Astellas Venture Capital L.L.C.

D

DEM Biopharma, Inc. raised $70M on June 23, 2022

Investors: UTokyo Innovation Platform Co., Ltd., Longwood Fund, Insight Partners, Alta Partners, Emerson Collective and Astellas Venture Capital L.L.C.

C

Carbon Biosciences raised $38M on June 21, 2022

Investors: Longwood Fund, Camford Capital, UTokyo Innovation Platform Co., Ltd., Solasta Ventures, Agent Capital and Astellas Venture Capital L.L.C.

T

Turn Biotechnologies raised undisclosed on April 11, 2022

Investors: Khosla Ventures, Shanda Group, ThreeD Capital Inc., Formic Ventures, LongeVC, HanAll BioPharma Co., Ltd, Methuselah Fund and Astellas Venture Capital L.L.C.

M

Mogrify raised $17M on May 4, 2021

Investors: Parkwalk Advisors, 24Haymarket and Astellas Venture Capital L.L.C.

U

Undisclosed raised $45M on March 23, 2021

Investors: XtalPi Inc., Parkwalk Advisors, Morningside Venture Capital 晨兴资本, o2h ventures and Astellas Venture Capital L.L.C.

N

NeoPhore Ltd raised $21M on March 9, 2021

Investors: SIXTH ELEMENT CAPITAL LLP, 3B Future Health Fund, 2invest financial, Claris Ventures SGR SpA and Astellas Venture Capital L.L.C.

FAQ